{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:00:07Z","timestamp":1793638807475,"version":"4.5.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.joca.2014.12.019","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T12:17:00Z","timestamp":1420805820000},"page":"532-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4764-5100","authenticated-orcid":false,"given":"M.A.","family":"Karsdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Byrjalsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0047-2756","authenticated-orcid":false,"given":"P.","family":"Alexandersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bihlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Riis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2014.12.019_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.21258","article-title":"Osteoarthritis","volume":"213","author":"Goldring","year":"2007","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.joca.2014.12.019_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2005.09.007","article-title":"Osteoarthritis: epidemiology","volume":"20","author":"Arden","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.joca.2014.12.019_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.joca.2009.08.010","article-title":"Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis","volume":"18","author":"Blagojevic","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.12.019_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0002-9343(02)01447-X","article-title":"Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors","volume":"114","author":"Karlson","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.joca.2014.12.019_bib5","first-page":"161","article-title":"Obesity and osteoarthritis: more than just wear and tear","volume":"21","author":"Koonce","year":"2013","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.joca.2014.12.019_bib6","first-page":"621","article-title":"Osteoarthritis and obesity","volume":"62","author":"Sellam","year":"2012","journal-title":"Rev Prat"},{"key":"10.1016\/j.joca.2014.12.019_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/bmj.312.7036.940","article-title":"Genetic influences on osteoarthritis in women: a twin study","volume":"312","author":"Spector","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2014.12.019_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/art.37726","article-title":"Valgus malalignment is a risk factor for lateral knee osteoarthritis incidence and progression: findings from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative","volume":"65","author":"Felson","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.12.019_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-133-5-200009050-00007","article-title":"Joint injury in young adults and risk for subsequent knee and hip osteoarthritis","volume":"133","author":"Gelber","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joca.2014.12.019_bib10","first-page":"285","article-title":"Rationale for the potential use of calcitonin in osteoarthritis","volume":"5","author":"Manicourt","year":"2005","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.joca.2014.12.019_bib11","doi-asserted-by":"crossref","first-page":"s88","DOI":"10.1016\/S1063-4584(05)80515-1","article-title":"Efficacy of calcitonin therapy in patients with knee osteoarthritis: a clinical and biochemical preliminary study","volume":"13","author":"Manicourt","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.12.019_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1196\/annals.1402.041","article-title":"Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis?","volume":"1117","author":"Karsdal","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.joca.2014.12.019_bib13","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/art.22075","article-title":"Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis","volume":"54","author":"Manicourt","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.12.019_bib14","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1359\/JBMR.040609","article-title":"Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency","volume":"19","author":"Behets","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.joca.2014.12.019_bib15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.joca.2004.08.005","article-title":"Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis","volume":"12","author":"El Hajjaji","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.12.019_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00228-009-0735-3","article-title":"Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy","volume":"66","author":"Karsdal","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.joca.2014.12.019_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.joca.2009.08.004","article-title":"The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study","volume":"18","author":"Karsdal","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.12.019_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2474-11-125","article-title":"Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis\u2013the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation","volume":"11","author":"Karsdal","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.joca.2014.12.019_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2474-11-62","article-title":"Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes","volume":"11","author":"Sondergaard","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.joca.2014.12.019_bib20","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/092986730611220401164504","article-title":"Calcitonin","volume":"6","author":"Sexton","year":"1999","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.joca.2014.12.019_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08977190410001728033","article-title":"Calcitonin","volume":"22","author":"Findlay","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.joca.2014.12.019_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bone.2005.04.032","article-title":"Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis","volume":"37","author":"Bagger","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.joca.2014.12.019_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6904-8-12","article-title":"Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin","volume":"8","author":"Karsdal","year":"2008","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.joca.2014.12.019_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2125.2009.03371.x","article-title":"Influence of food intake on the bioavailability and efficacy of oral calcitonin","volume":"67","author":"Karsdal","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.joca.2014.12.019_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6904-8-5","article-title":"Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin","volume":"8","author":"Karsdal","year":"2008","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.joca.2014.12.019_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0091270008329552","article-title":"A\u00a0pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitonin","volume":"49","author":"Karsdal","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.joca.2014.12.019_bib27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0091270010372625","article-title":"Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials","volume":"51","author":"Karsdal","year":"2010","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.joca.2014.12.019_bib28","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2014.12.019_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.joca.2013.10.018","article-title":"Osteoarthritis\u2013a case for personalized health care?","volume":"22","author":"Karsdal","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.12.019_bib30","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1002\/art.22160","volume":"54","author":"Bingham","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.12.019_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/rheumatology\/kel213","article-title":"A\u00a02 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients","volume":"46","author":"Buckland-Wright","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2014.12.019_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2012-202231","article-title":"Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial","volume":"72","author":"Reginster","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.12.019_bib33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2174\/1568026043387935","article-title":"The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE","volume":"4","author":"Levin","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.joca.2014.12.019_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/annrheumdis-2012-202239","article-title":"A\u00a02-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee","volume":"72","author":"Hellio Le Graverand","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.12.019_bib35","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.21122","article-title":"Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial","volume":"52","author":"Brandt","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.12.019_bib36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/ard.2010.147967","article-title":"The effects of doxycycline on reducing symptoms in knee osteoarthritis: results from a triple-blinded randomised controlled trial","volume":"70","author":"Snijders","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.12.019_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4081\/rr.2009.e12","article-title":"Role of calcitonin in management of musculoskeletal pain","volume":"1","author":"Arendt-Nielsen","year":"2009","journal-title":"Rheumatol Rep"},{"key":"10.1016\/j.joca.2014.12.019_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard.2004.022905","article-title":"Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement","volume":"64","author":"Tubach","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.12.019_bib39","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.pain.2013.04.033","article-title":"Widespread sensitization in patients with chronic pain after revision total knee arthroplasty","volume":"154","author":"Skou","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.joca.2014.12.019_bib40","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.37884","article-title":"Normalization of widespread pressure pain hypersensitivity after total hip replacement in patients with hip osteoarthritis is associated with clinical and functional improvements","volume":"65","author":"randa-Villalobos","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.12.019_bib41","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/art.34466","article-title":"Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement","volume":"64","author":"Graven-Nielsen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.12.019_bib42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.04.003","article-title":"Sensitization in patients with painful knee osteoarthritis","volume":"149","author":"rendt-Nielsen","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.joca.2014.12.019_bib43","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1359\/JBMR.040715","article-title":"Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover","volume":"19","author":"Tanko","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.joca.2014.12.019_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0002-9440(10)62269-9","article-title":"Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption","volume":"166","author":"Karsdal","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joca.2014.12.019_bib45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.joca.2014.12.019_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2474-9-153","article-title":"Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation","volume":"9","author":"Karsdal","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.joca.2014.12.019_bib47","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/art.20332","article-title":"A\u00a0new marker for osteoarthritis: cross-sectional and longitudinal approach","volume":"50","author":"Reijman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.12.019_bib48","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar2774","article-title":"Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers","volume":"11","author":"Dam","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2014.12.019_bib49","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1136\/annrheumdis-2013-203726","article-title":"Value of biomarkers in osteoarthritis: current status and perspectives","volume":"72","author":"Lotz","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.12.019_bib50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.joca.2006.03.014","article-title":"Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA?","volume":"14","author":"Karsdal","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.12.019_bib51","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/1529-0131(199906)42:6<1159::AID-ANR12>3.0.CO;2-Q","article-title":"Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions","volume":"42","author":"Manicourt","year":"1999","journal-title":"Arthritis Rheum"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458414013934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458414013934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:36:30Z","timestamp":1761017790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458414013934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1063458414013934"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2014.12.019","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2014.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}